We selected NK cells to correlate with details of the patient’s clinical course because of the previous work describing MUC16 inhibition of synapse formation between NK cells and ovarian cancer tumor cells, thus preventing NK-cell tumoricidal function [5–7]. This evidence concerns the gene MUC16 and ovarian cancer.